SAN FRANCISCO--(BUSINESS WIRE)--Sequenta, Inc. today announced the launch of its new physician portal, the ClonoSIGHT Secure Portal (https://results.clonosight.com). The HIPAA-compliant online portal enables physicians to more effectively integrate the ClonoSIGHT process, an ultra-sensitive, next-generation sequencing-based technology for minimal residual disease (MRD) detection and quantification, into the care of patients with lymphoid cancers. Using the ClonoSIGHT Secure Portal, physicians c